Robert L. Grubb

6.9k total citations
74 papers, 2.3k citations indexed

About

Robert L. Grubb is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Robert L. Grubb has authored 74 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 9 papers in Surgery. Recurrent topics in Robert L. Grubb's work include Prostate Cancer Diagnosis and Treatment (43 papers), Prostate Cancer Treatment and Research (35 papers) and Global Cancer Incidence and Screening (8 papers). Robert L. Grubb is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (43 papers), Prostate Cancer Treatment and Research (35 papers) and Global Cancer Incidence and Screening (8 papers). Robert L. Grubb collaborates with scholars based in United States, Canada and Chile. Robert L. Grubb's co-authors include Gerald L. Andriole, Paul F. Pinsky, Amanda Black, J. F. Hahn, Robert A. Ratcheson, Dorit Aram, Harold L. Rekate, Philip C. Prorok, John K. Gohagan and Peter L. Choyke and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Robert L. Grubb

72 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert L. Grubb United States 25 1.5k 630 474 338 304 74 2.3k
Simon J. Hall United States 29 970 0.7× 511 0.8× 873 1.8× 522 1.5× 151 0.5× 88 2.9k
Robert Laing United Kingdom 26 1.3k 0.9× 244 0.4× 367 0.8× 282 0.8× 248 0.8× 81 2.1k
Esther Mena United States 29 1.7k 1.2× 357 0.6× 572 1.2× 245 0.7× 332 1.1× 127 3.4k
Bhupendra Rawal United States 26 705 0.5× 705 1.1× 958 2.0× 645 1.9× 246 0.8× 76 2.9k
Tanya Surawicz United States 20 736 0.5× 399 0.6× 1.0k 2.1× 600 1.8× 258 0.8× 39 3.4k
Marc Barry United States 18 511 0.4× 738 1.2× 420 0.9× 169 0.5× 248 0.8× 42 1.7k
Mahdi Fallah Germany 26 720 0.5× 563 0.9× 1.1k 2.2× 424 1.3× 302 1.0× 82 2.6k
H. Sauer Germany 24 402 0.3× 1.0k 1.6× 1.2k 2.5× 867 2.6× 347 1.1× 84 4.0k
Rizwan Hamid United States 27 1.2k 0.8× 689 1.1× 112 0.2× 260 0.8× 217 0.7× 85 2.5k
Richard L. Heideman United States 46 1.3k 0.9× 1.8k 2.8× 935 2.0× 477 1.4× 227 0.7× 117 5.5k

Countries citing papers authored by Robert L. Grubb

Since Specialization
Citations

This map shows the geographic impact of Robert L. Grubb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Grubb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Grubb more than expected).

Fields of papers citing papers by Robert L. Grubb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Grubb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Grubb. The network helps show where Robert L. Grubb may publish in the future.

Co-authorship network of co-authors of Robert L. Grubb

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Grubb. A scholar is included among the top collaborators of Robert L. Grubb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Grubb. Robert L. Grubb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Lee, Young Ho, Arpita Singha Roy, Rene Costello, et al.. (2021). Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder. PLoS ONE. 16(7). e0241766–e0241766. 5 indexed citations
4.
Yang, Lin, Jung Ae Lee, Emily Heer, et al.. (2021). One-year urinary and sexual outcome trajectories among prostate cancer patients treated by radical prostatectomy: a prospective study. BMC Urology. 21(1). 81–81. 4 indexed citations
5.
Landy, Rebecca, Lauren C. Houghton, Christine D. Berg, et al.. (2020). Risk of Prostate Cancer–related Death Following a Low PSA Level in the PLCO Trial. Cancer Prevention Research. 13(4). 367–376. 7 indexed citations
6.
7.
Mossanen, Matthew, Kenneth G. Nepple, Robert L. Grubb, et al.. (2018). Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy. European Urology Oncology. 1(2). 143–148. 16 indexed citations
8.
Weaver, John, Eric H. Kim, Joel Vetter, et al.. (2017). Prostate Magnetic Resonance Imaging Provides Limited Incremental Value Over the Memorial Sloan Kettering Cancer Center Preradical Prostatectomy Nomogram. Urology. 113. 119–128. 29 indexed citations
9.
Skolarus, Ted A., Soohyun Hwang, Hyungjin Myra Kim, et al.. (2017). Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial. Trials. 18(1). 181–181. 8 indexed citations
10.
Verma, Vivek, Ling Chen, Jeff M. Michalski, et al.. (2014). Evaluation of 3 T pelvic MRI imaging in prostate cancer patients receiving post-prostatectomy IMRT. World Journal of Urology. 33(1). 69–75. 8 indexed citations
11.
Pinsky, Paul F., Amanda Black, Howard L. Parnes, et al.. (2012). Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer Epidemiology. 36(6). e401–e406. 13 indexed citations
12.
Pinsky, Paul F., Amanda Black, Robert L. Grubb, et al.. (2012). Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials. Cancer. 119(3). 593–601. 17 indexed citations
13.
Sutcliffe, Siobhan, Robert L. Grubb, Elizabeth A. Platz, et al.. (2012). Non‐steroidal anti‐inflammatory drug use and the risk of benign prostatic hyperplasia‐related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. British Journal of Urology. 110(7). 1050–1059. 29 indexed citations
14.
Crawford, E. David, Robert L. Grubb, Amanda Black, et al.. (2010). Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial. Journal of Clinical Oncology. 29(4). 355–361. 98 indexed citations
15.
Skolarus, Ted A., Katherine S. Virgo, Matthew D. Katz, et al.. (2009). Intravesical Bacille Calmette-Guérin Therapy for Non-Muscle-Invasive Bladder Cancer: Effects of Concurrent Statin Therapy. Journal of the American College of Surgeons. 209(2). 248–253. 12 indexed citations
16.
Pinsky, Paul F., E. David Crawford, Barnett S. Kramer, et al.. (2007). Repeat prostate biopsy in the Prostate, Lung, Colorectal and Ovarian cancer screening trial. British Journal of Urology. 99(4). 775–779. 29 indexed citations
17.
Pinsky, Paul F., Gerald L. Andriole, E. David Crawford, et al.. (2007). Prostate‐specific antigen velocity and prostate cancer gleason grade and stage. Cancer. 109(8). 1689–1695. 44 indexed citations
18.
Grubb, Robert L. & Gerald L. Andriole. (2006). Can preoperative PSA doubling time and PSA velocity predict outcomes following radical prostatectomy?. Nature Clinical Practice Urology. 3(6). 306–307. 2 indexed citations
19.
Grubb, Robert L., Valerie Calvert, Cloud P. Paweletz, et al.. (2003). Signal pathway profiling of prostate cancer using reverse phase protein arrays. PROTEOMICS. 3(11). 2142–2146. 147 indexed citations
20.
Grubb, Robert L.. (1999). Obituary: Henry G. Schwartz, M.D. 1909–1998. Journal of neurosurgery. 90(3). 599–602. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon J. Hall Breakdown of academic impact, for papers by Robert Laing Breakdown of academic impact, for papers by Esther Mena Breakdown of academic impact, for papers by Bhupendra Rawal Breakdown of academic impact, for papers by Tanya Surawicz Breakdown of academic impact, for papers by Marc Barry Breakdown of academic impact, for papers by Mahdi Fallah Breakdown of academic impact, for papers by H. Sauer Breakdown of academic impact, for papers by Rizwan Hamid Breakdown of academic impact, for papers by Richard L. Heideman
Rankless by CCL
2026